Carlyle Group (CG)
(Delayed Data from NSDQ)
$45.62 USD
-0.50 (-1.08%)
Updated Apr 25, 2024 04:00 PM ET
After-Market: $46.59 +0.97 (2.13%) 7:48 PM ET
2-Buy of 5 2
D Value F Growth A Momentum F VGM
Price, Consensus and EPS Surprise
CG 45.62 -0.50(-1.08%)
Will CG be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for CG based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for CG
Top 5 Nasdaq-Listed, Non-Tech Stocks Set to Beat on Q1 Earnings
What Makes Carlyle (CG) a New Buy Stock
CG: What are Zacks experts saying now?
Zacks Private Portfolio Services
Carlyle Group (CG) is a Top Dividend Stock Right Now: Should You Buy?
This is Why Carlyle Group (CG) is a Great Dividend Stock
Should You Watch Truist (TFC) to Earn Solid Dividend Yield?
Other News for CG
Net Health Secures Dr. Drew Contreras and Geeta "Dr. G" Nayyar to Speak at First-Ever Rehab Therapy and Wound Care Product Summit
Polaris Global Equity Composite Q1 2024 Commentary
Looking Into Carlyle Group's Recent Short Interest
Analysts Offer Insights on Financial Companies: AMP Limited (OtherAMLTF), First Horizon (FHN) and Carlyle Group (CG)
Raymond James Reaffirms Their Buy Rating on Centerra Gold (CGAU)